Delivery Order SPE2DB24D1021-SPE2DB25FEYLH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Gel-One 30 mg/3 ml syringes with a ceiling value of $14,596.00. The contract represents a firm fixed price delivery order with an ultimate completion date of October 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively awarded with no set-aside designation, reflecting the vendor's...
- The Defense Logistics Agency awarded a delivery order valued at $5,473.50 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Gel-One 30 mg/3 ml syringes. This competitive, firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,824.50 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on July 30, 2025, with an ultimate completion date of August 20, 2025. This competitive contract award, which carries no set-aside designation, is structured as a firm fixed price delivery order. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $9,122.50 to AmerisourceBergen Drug Corp for Gel-One 30 mg/3 mL syringes (3 mL units) on September 23, 2025, with completion targeted for October 15, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Gel-One 30 mg/3 mL syringes in 3 mL quantities, with a contract ceiling value of $3,649.00 and an ultimate completion date of October 1, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,298.00 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price contract, with an ultimate completion date of September 4, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. The contract was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $1,094.70. This is a firm fixed-price delivery order with an ultimate completion date of September 8, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Gel-One 30 mg/3 mL syringes with a ceiling value of $3,649.00. This is a firm fixed price delivery order with an ultimate completion date of August 1, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a $3,649 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Gel-One 30 mg/3 mL syringes. This firm fixed-price delivery order is expected to be completed by August 12, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $18,245.00 to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes on September 22, 2025. The contract is structured as a firm fixed price delivery order with an ultimate completion date of October 14, 2025, and carries no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEYLHDelivery Order
The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Gel-One 30 mg/3 mL syringes, with a contract ceiling value of $7,298.00. The award, issued on July 10, 2025, is a firm fixed-price delivery order with an ultimate completion date of July 31, 2025. This delivery order carries no set-aside designation and was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. Through this contract vehicle, the company provides critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, and related medical supplies across multiple therapeutic domains to support the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 7/10/25 |